The Ardis Detox Layer: NAC, Dandelion Root, Pine Needle, Methylene Blue & the Spike-Clearance Stack

Table of Contents

  1. The Layered-Detox Framework
  2. NAC: The Glutathione Foundation
  3. Vitamin C: The High-Dose Antioxidant Layer
  4. Dandelion Root: Spike-Binding Botanical
  5. Pine Needle Tea & Shikimic Acid
  6. Nattokinase & Serrapeptase: Microclot Dissolution
  7. Low-Dose Aspirin
  8. Methylene Blue: Mitochondrial Bypass
  9. Fenbendazole: The Cancer-Immunology Layer
  10. Ivermectin: Off-Label Antiviral & Anti-Inflammatory
  11. Melatonin: High-Dose Anti-Inflammatory
  12. Zinc & Quercetin: The Ionophore Pair
  13. Vitamin D3, K2, Magnesium
  14. The Chelation Question
  15. Sequencing the Stack — Don’t Add Everything at Once
  16. Key Research Papers
  17. PubMed Research Searches
  18. Connections

1. The Layered-Detox Framework

The Ardis detox layer sits underneath nicotine receptor-saturation therapy and aims to address four pathophysiological targets identified in spike-mediated illness:

  1. Glutathione depletion — the master cellular antioxidant is consumed by spike-induced oxidative stress.
  2. Persistent spike protein — circulating and exosomal spike beyond the acute window.
  3. Microclot formation — amyloid-fibrin microclots resistant to ordinary fibrinolysis (Pretorius lab).
  4. Mitochondrial dysfunction — reduced electron-transport efficiency, drop in ATP production, fatigue phenotype.

The detox layer addresses each in turn. The receptor-saturation layer (nicotine) prevents further spike-mediated injury at the cell surface. The detox layer cleans up the damage already done.

2. NAC: The Glutathione Foundation

N-acetylcysteine (NAC) is the most consistently emphasized supplement across the entire post-COVID and post-vaccination protocol literature. Mechanism:

Dosing: 600 mg twice daily on empty stomach is the conservative therapeutic dose. The Ardis protocol uses 600–1,800 mg daily. Higher doses (3,600+ mg) are tolerated but may produce GI upset.

Notes: the FDA briefly attempted to remove NAC from supplement status in 2020–2021, citing its IND status for acetaminophen overdose. This regulatory move was widely interpreted as an attempt to suppress its COVID-era use; the position was eventually reversed. NAC remains widely available OTC. Full discussion at NAC.

3. Vitamin C: The High-Dose Antioxidant Layer

Vitamin C is the second pillar of the antioxidant layer:

For long-term use, whole-food vitamin C (acerola, camu camu, rose hip) is preferred by many functional-medicine practitioners over isolated ascorbic acid. See Vitamin C.

4. Dandelion Root: Spike-Binding Botanical

Dandelion (Taraxacum officinale) root extract was identified in a 2021 in-vitro screen by Tran et al. as a potential inhibitor of SARS-CoV-2 spike RBD binding to ACE2. The preprint generated significant attention in the post-COVID-recovery community and was incorporated into multiple recovery protocols.

Dandelion-root tea is one of the safest supplemental layers in the Ardis protocol. Even if the in-vitro spike-binding mechanism turns out to be modest in vivo, the hepatobiliary and microbiome benefits are real.

5. Pine Needle Tea & Shikimic Acid

Pine-needle tea is a traditional respiratory and immune remedy across multiple cultures (Indigenous North American, Korean solip-cha, Russian khvoya, ancient Greek/Roman). It is rich in shikimic acid, the precursor used industrially to synthesize oseltamivir (Tamiflu) and a range of phenolic compounds (quercetin, ferulic acid, etc.).

Pine-needle tea is the kind of low-cost, low-tech intervention the Ardis case points to as having been deliberately sidelined by a pharmaceutical-industrial complex that profits more from $3,120 antivirals than from herb-of-the-hedgerow remedies. The empirical case is modest; the historical case for safety is strong.

6. Nattokinase & Serrapeptase: Microclot Dissolution

The amyloid-fibrin microclots described by Pretorius and colleagues in long-COVID and post-vaccination patients are resistant to ordinary fibrinolysis. Two enzymes show in-vitro activity against this clot phenotype:

The Pretorius lab has published clinical case series on protocols using nattokinase + apixaban + clopidogrel in long-COVID with documented microclot reduction on imaging. Direct anticoagulant + antiplatelet + nattokinase combinations are physician-supervised; OTC use of nattokinase alone is straightforward.

7. Low-Dose Aspirin

Low-dose aspirin (81 mg daily) is the most-studied antiplatelet agent in medicine and a reasonable supportive layer for the microclot phenotype. Mechanism: irreversible COX-1 inhibition in platelets, reducing thromboxane A2 production and platelet aggregation.

See Aspirin for full discussion.

8. Methylene Blue: Mitochondrial Bypass

Methylene blue is a 19th-century synthetic dye that has been used as a pharmaceutical agent for over a century. In the recovery context, it is used for its mitochondrial electron-transport bypass activity at low doses (0.5–4 mg/kg), which can rescue cellular energetics in tissues with damaged Complex IV / cytochrome-c oxidase.

See Methylene Blue for the full mechanism, dosing, and safety discussion.

9. Fenbendazole: The Cancer-Immunology Layer

Fenbendazole is a benzimidazole anthelmintic licensed for veterinary use. It has been studied for repurposed oncological use after the Joe Tippens case (a small-cell lung-cancer survivor whose remission was attributed to fenbendazole) gained popular attention. Mechanism candidates: tubulin disruption, glucose-uptake inhibition in cancer cells, p53 stabilization.

See Fenbendazole for the full evidence review.

10. Ivermectin: Off-Label Antiviral & Anti-Inflammatory

Ivermectin is a Nobel-Prize-winning macrocyclic lactone (the 2015 Nobel Prize in Physiology or Medicine went to Satoshi Ōmura and William Campbell for its discovery) with a 30-year human safety record across more than 4 billion doses for parasitic infections. In-vitro and clinical data supporting use in COVID-19 has been the subject of intense controversy.

This page is documentation; actual decisions about ivermectin use are between patient and physician within applicable law.

11. Melatonin: High-Dose Anti-Inflammatory

Melatonin’s role in recovery protocols is anti-inflammatory and mitochondrial-protective, far beyond its sleep-promoting reputation. The Reiter laboratory has documented:

Dosing in recovery protocols: 5–20 mg at bedtime. Far higher than the 0.3–3 mg conventional sleep dose. Safety profile is excellent — high-dose melatonin (up to 1 g daily in select studies) has been administered without significant adverse events. Subjective “next-day grogginess” is the dose-limiting factor for most users.

12. Zinc & Quercetin: The Ionophore Pair

Zinc has direct antiviral activity at the level of viral RNA polymerase inhibition. The challenge with zinc supplementation is that intracellular delivery is rate-limiting — zinc ions do not cross cell membranes easily. Ionophores carry zinc into cells.

See Zinc.

13. Vitamin D3, K2, Magnesium

The vitamin D / K2 / magnesium triad is foundational across all the post-COVID recovery protocols:

See Vitamin D3, Magnesium.

14. The Chelation Question

Heavy-metal chelation (EDTA, DMSA, DMPS) is not part of the standard Ardis protocol. The reasoning:

Gentle natural-binders (chlorella, modified citrus pectin, activated charcoal in select uses) are reasonable supplemental layers and are part of the broader detox-protocol literature. See Detox Protocols for the broader Phase-I/II/III liver-detoxification framework that contextualizes the Ardis layer.

15. Sequencing the Stack — Don’t Add Everything at Once

The single most common mistake patients make with the Ardis protocol is starting all 12 supplements on day one. Realistic sequencing:

  1. Day 1: NAC, vitamin D3, magnesium, vitamin C, melatonin. Establish tolerance.
  2. Day 3: Add nicotine patch (half of 7 mg). Establish tolerance.
  3. Day 7: Step nicotine to full 7 mg. Add zinc + quercetin.
  4. Day 14: Add dandelion-root tea, pine-needle tea (if appropriate species available and identifiable).
  5. Day 21: Add nattokinase if D-dimer elevated. Add low-dose aspirin if no bleeding contraindication.
  6. Day 30 / Phase 3: Layer methylene blue (if not on serotonergic medications), CoQ10, L-carnitine for mitochondrial support.
  7. As needed: LDN, ivermectin, fenbendazole based on clinical phenotype and physician partnership.

This sequencing allows tolerance assessment at each step and avoids the “something in this protocol made me feel worse but I can’t tell which one” trap.

Key Research Papers

  1. Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging. Diabetes Care. 2011;34(1):162-167.
  2. Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in Long COVID/PASC. Cardiovasc Diabetol. 2021;20(1):172.
  3. Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto. Experientia. 1987;43:1110-1111.
  4. Reiter RJ, Ma Q, Sharma R. Treatment of Ebola and other infectious diseases: melatonin ‘goes viral’. Melatonin Res. 2020;3(1):43-57.
  5. Mrowietz U, Asadullah K, et al. Methylene blue: a quintessential pharmacological mainstay. Int J Cancer.
  6. Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260-1263.
  7. Tran HTT, et al. Taraxacum officinale (dandelion) inhibits SARS-CoV-2 spike protein binding to ACE2. bioRxiv preprint, 2021.

Back to Table of Contents

PubMed Research Searches

  1. PubMed: NAC, glutathione, and COVID
  2. PubMed: Dandelion root and SARS spike
  3. PubMed: Nattokinase and fibrin
  4. PubMed: Methylene blue and mitochondria
  5. PubMed: Melatonin, inflammation, coronavirus
  6. PubMed: Quercetin and zinc ionophore
  7. PubMed: Vitamin D and COVID mortality
  8. PubMed: Fenbendazole and cancer
  9. PubMed: Ivermectin and long-COVID

Back to Table of Contents

Connections

Back to Table of Contents